Should clinical/commercial laboratories maintain the capacity to perform culture tests?
Yes, it is important that clinical and commercials labs be able to detect emerging mutations.
91%
No, public health surveillance should adapt to increasingly popular culture-independent testing methodologies.
9%
See this poll on:
https://poll.fm/9428481/embed
